The FDA has ruled that Pfizer violated the Federal Food, Drug and Cosmetic Act with a false or misleading advertisement in a medical journal, which claims Geodon (ziprasidone mesylate) for Injection has "proven advantages over haloperidol IM-twice the improvement as measured on the BPRS." (Brook S, et al, J Clin Psychiatry 2000;61:933-941.) This claim, according to the FDA, "has not been demonstrated by substantial evidence or substantial clinical experience."

The ad fails to list side effects...